Gilles Divita

Company: Divincell

Job title: Chief Executive Officer

Seminars:

Panel Discussion — Finding the Right Partnership to Build a Robust & Trusting Relationship to Accelerate mRNA Development Into the Clinic 3:00 pm

The mRNA community thrives on strategic alliances, which allow for cross-functional sharing of knowledge, skills, and experience across different disciplines to truly advance mRNA technologies to accelerate drug development to patients faster. This panel will explore: How to overcome the complexities of decision-making and cultural boundaries for developing, acquiring, licensing and advancing innovative approaches Where…Read more

day: Day 1 Track 2 PM

mRNA & Gene Editing – Delineating the Convergence of mRNA’s Potential as a Tool to Treat Genetic Diseases 12:45 pm

With the UK approval of the world’s first gene-editing treatment for blood cancer, the race is now on to develop next-generation gene editing technologies leveraging mRNA technology with the mission to develop curative therapies for some of the most challenging genetic diseases. With a convergence of academic and industry collaborations to focus on bringing these…Read more

day: mRNA Technology & Innovation Day